SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-17-014488
Filing Date
2017-08-11
Accepted
2017-08-11 12:37:32
Documents
52
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q plxp20170630_10q.htm 10-Q 956823
2 EXHIBIT 3.3 ex3-3.htm EX-3.3 22800
3 EXHIBIT 31.1 ex31-1.htm EX-31.1 10247
4 EXHIBIT 31.2 ex31-2.htm EX-31.2 10431
5 EXHIBIT 32.1 ex32-1.htm EX-32.1 6422
6 EXHIBIT 32.2 ex32-2.htm EX-32.2 6775
  Complete submission text file 0001437749-17-014488.txt   3972507

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT plxp-20170630.xml EX-101.INS 540946
8 XBRL TAXONOMY EXTENSION SCHEMA plxp-20170630.xsd EX-101.SCH 43017
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE plxp-20170630_cal.xml EX-101.CAL 34406
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE plxp-20170630_def.xml EX-101.DEF 329405
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE plxp-20170630_lab.xml EX-101.LAB 302724
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plxp-20170630_pre.xml EX-101.PRE 340457
Mailing Address 8285 EL RIO STREET SUITE 130 HOUSTON TX 77054
Business Address 8285 EL RIO STREET SUITE 130 HOUSTON TX 77054 (713) 842-1249
PLx Pharma Inc. (Filer) CIK: 0001497504 (see all company filings)

IRS No.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36351 | Film No.: 171023919
SIC: 2834 Pharmaceutical Preparations